Fluidiconic Biotechnology aims to redefine preclinical drug screening through tumor microenvironment simulation.
Our core product series, MedSelect™ platforms, create microfluidic-based 3D co-culture system that replicates key features of the ex vivo tumor microenvironment. It enables precise evaluation of drug response, immune cell behavior, and tissue-level gradients in real time.
Applications include preclinical optimization, reduction of animal testing, and patient-specific drug response profiling. We welcome collaborations with pharma, CROs, and research teams to accelerate ethical, efficient oncology innovation.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 1f., No. 1, Lixing 1st Rd., East Dist.,, Hsinchu City,300094,taiwan, Province Of China
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://fcbio.net/
- HQ
- Hsinchu city
Fluidiconic Biotechnology Questions
Fluidiconic Biotechnology's website is https://fcbio.net/
Fluidiconic Biotechnology's LinkedIn profile is https://tw.linkedin.com/company/fluidiconic
Fluidiconic Biotechnology has
4 employees.
View email and phone details for 4
employees at Fluidiconic Biotechnology.
Fluidiconic Biotechnology's industry is
Biotechnology Research
Fluidiconic Biotechnology's top competitors are
Guzip Biomarkers Corp.,
Biochip Labs,
Bioleap,
Global Bio & Investment Monthly,
歆湘種苗 Plantsing Culture,
Trinity 3, Llc,
貝克生醫,
Vedan Enterprise Corp.,
Tibia Usa (Taiwan Biomedical Innovative Association),
Biochip Systems.
Fluidiconic Biotechnology's categories are Biotechnology Research
Fluidiconic Biotechnology's founding year is 2023
